The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
Shahrad Hakimian,1 Yevgeniy Popov,1 Abbas H Rupawala,2 Karen Salomon-Escoto,3 Steven Hatch,4 Randall Pellish1,2 1Department of Medicine, 2Division of Gastroenterology, 3Division of Rheumatology, 4Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA Background: Tumor necr...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9826e472f5747949dfcb09d3002e73c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d9826e472f5747949dfcb09d3002e73c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d9826e472f5747949dfcb09d3002e73c2021-12-02T07:15:07ZThe conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation1177-5491https://doaj.org/article/d9826e472f5747949dfcb09d3002e73c2018-02-01T00:00:00Zhttps://www.dovepress.com/the-conundrum-of-indeterminate-quantiferon-tb-gold-results-before--ant-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Shahrad Hakimian,1 Yevgeniy Popov,1 Abbas H Rupawala,2 Karen Salomon-Escoto,3 Steven Hatch,4 Randall Pellish1,2 1Department of Medicine, 2Division of Gastroenterology, 3Division of Rheumatology, 4Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA Background: Tumor necrosis factor alpha (TNFα) is a key cytokine in both the pathogenesis of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) and the host defense against tuberculosis (TB). Consequently, anti-TNFα medications result in an increased risk of latent TB infection (LTBI) reactivation. Here, we sought to evaluate the factors affecting the results of QuantiFERON-TB Gold In-Tube (QFT-GIT) assay as a screening tool for LTBI. Methods: We conducted an observational, retrospective study in patients with IBD and RA who underwent LTBI screening using QFT-GIT at UMass Memorial Medical Center between 2008 and 2016 prior to initiation of anti-TNF medications. Results: We included 107 and 89 patients with IBD and RA, respectively. We found that a higher proportion of IBD patients had indeterminate QFT-GIT result compared to RA patients. Furthermore, we found that the majority of patients with indeterminate results were tested during an acute flare of IBD (88%) and while taking corticosteroids. Of all patients receiving ≥20 mg equivalent prednisone dose (n=32), 63% resulted in indeterminate QFT-GIT, compared to only 6% indeterminate testing in patients receiving <20 mg of equivalent prednisone dose (n=164, P<0.001). There was no correlation between indeterminate results and age, gender, disease duration, or distribution, or smoking status within each population. Conclusion: We observed that high-dose corticosteroids may affect QFT-GIT outcomes leading to a high proportion of indeterminate results. We propose that IBD patients should be tested prior to initiation of corticosteroids to avoid equivocal results and prevent potential delays in initiation of anti-TNF medications. Keywords: indeterminate QuantiFERON-TB Gold, latent TB infection, inflammatory bowel disease, rheumatoid arthritis, corticosteroids, IBD flareHakimian SPopov YRupawala AHSalomon-Escoto KHatch SPellish RDove Medical PressarticleIndeterminate Quantiferon GoldLatent TB infectionInflammatory Bowel DiseaseRheumatoid ArthritisMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 12, Pp 61-67 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Indeterminate Quantiferon Gold Latent TB infection Inflammatory Bowel Disease Rheumatoid Arthritis Medicine (General) R5-920 |
spellingShingle |
Indeterminate Quantiferon Gold Latent TB infection Inflammatory Bowel Disease Rheumatoid Arthritis Medicine (General) R5-920 Hakimian S Popov Y Rupawala AH Salomon-Escoto K Hatch S Pellish R The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation |
description |
Shahrad Hakimian,1 Yevgeniy Popov,1 Abbas H Rupawala,2 Karen Salomon-Escoto,3 Steven Hatch,4 Randall Pellish1,2 1Department of Medicine, 2Division of Gastroenterology, 3Division of Rheumatology, 4Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA Background: Tumor necrosis factor alpha (TNFα) is a key cytokine in both the pathogenesis of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) and the host defense against tuberculosis (TB). Consequently, anti-TNFα medications result in an increased risk of latent TB infection (LTBI) reactivation. Here, we sought to evaluate the factors affecting the results of QuantiFERON-TB Gold In-Tube (QFT-GIT) assay as a screening tool for LTBI. Methods: We conducted an observational, retrospective study in patients with IBD and RA who underwent LTBI screening using QFT-GIT at UMass Memorial Medical Center between 2008 and 2016 prior to initiation of anti-TNF medications. Results: We included 107 and 89 patients with IBD and RA, respectively. We found that a higher proportion of IBD patients had indeterminate QFT-GIT result compared to RA patients. Furthermore, we found that the majority of patients with indeterminate results were tested during an acute flare of IBD (88%) and while taking corticosteroids. Of all patients receiving ≥20 mg equivalent prednisone dose (n=32), 63% resulted in indeterminate QFT-GIT, compared to only 6% indeterminate testing in patients receiving <20 mg of equivalent prednisone dose (n=164, P<0.001). There was no correlation between indeterminate results and age, gender, disease duration, or distribution, or smoking status within each population. Conclusion: We observed that high-dose corticosteroids may affect QFT-GIT outcomes leading to a high proportion of indeterminate results. We propose that IBD patients should be tested prior to initiation of corticosteroids to avoid equivocal results and prevent potential delays in initiation of anti-TNF medications. Keywords: indeterminate QuantiFERON-TB Gold, latent TB infection, inflammatory bowel disease, rheumatoid arthritis, corticosteroids, IBD flare |
format |
article |
author |
Hakimian S Popov Y Rupawala AH Salomon-Escoto K Hatch S Pellish R |
author_facet |
Hakimian S Popov Y Rupawala AH Salomon-Escoto K Hatch S Pellish R |
author_sort |
Hakimian S |
title |
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation |
title_short |
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation |
title_full |
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation |
title_fullStr |
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation |
title_full_unstemmed |
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation |
title_sort |
conundrum of indeterminate quantiferon-tb gold results before anti-tumor necrosis factor initiation |
publisher |
Dove Medical Press |
publishDate |
2018 |
url |
https://doaj.org/article/d9826e472f5747949dfcb09d3002e73c |
work_keys_str_mv |
AT hakimians theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT popovy theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT rupawalaah theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT salomonescotok theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT hatchs theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT pellishr theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT hakimians conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT popovy conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT rupawalaah conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT salomonescotok conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT hatchs conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation AT pellishr conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation |
_version_ |
1718399547412054016 |